Accessibility List

Markets

  1. Home
Market Nav

HIKAL LTD.

  • NSE CodeHIKALEQ
  • BSE Code524735
  • ISININE475B01022
  • IndustryPharmaceuticals

Company Information

Management

Jai Hiremath

Executive Chairman

Incorporation Year

08/07/1988

Registered Address


Mumbai, Maharashtra - 400021
Tel: 022-62770299
Fax: 022-22833913

Registrar Office

MUFG Intime India Pvt. Ltd.
C 101, 247 Park, L.B.S. Marg, Vikhroli (West)
Mumbai,400083,Maharashtra
Tel: 022-49186270
Fax: 49186060

Email

info@hikal.com

Website

http://www.hikal.com

Listing

BSE, MCXSX, NSE

Corporate News

Hikal - Trading Window

25-Mar-2026|6:22PM

Hikal Limited has informed the Exchange regarding the Trading Window closur

Hikal - Updates

18-Feb-2026|5:03PM

Hikal Limited has informed the Exchange regarding 'Intimation Under Regulat

Hikal - Intimation Under Regulation 7 (2) Of SEBI Pro...

18-Feb-2026|5:03PM

Intimation Under Regulation 7 (2) of SEBI Prohibition of Insider Trading Re

Hikal - Disclosure under SEBI Takeover Regulations

18-Feb-2026|4:33PM

ÿCastilia Life Sciences LLPÿhas submitted to the Exchange a copy of Disclos

More

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug53.71152.29
Aarti Drug352.703,219.09
Aarti Pharma645.655,853.32
Abbott India26,285.0055,853.79
Accent Micro380.60913.02
More

MF Holding

Scheme NameValue
(₹ Cr)		Holding (%)
ICICI P..78.461.15
Tata Sm..64.900.61
Tata In..7.750.60
Motilal..2.330.10
Motilal..0.020.05
More

Board Meetings

DatePurpose
11/02/2026Quarterly Results &..
13/11/2025Quarterly Results
07/08/2025Quarterly Results
14/05/2025Audited Results & F..
04/02/2025Quarterly Results &..
More